XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation
Clinical trial NCT06936527 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06936527
- Sponsor
- NovaOnco Therapeutics Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-23
- Primary completion
- 2028-04-30
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.